Zions Bancorporation’s Nomura Holdings NMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $8.3K | Sell |
1,434
-370
| -21% | -$2.1K | ﹤0.01% | 643 |
|
|
2024
Q3 | $9.42K | Sell |
1,804
-699
| -28% | -$3.97K | ﹤0.01% | 629 |
|
|
2024
Q2 | $14.5K | Sell |
2,503
-861
| -26% | -$5.1K | ﹤0.01% | 604 |
|
|
2024
Q1 | $21.6K | Hold |
3,364
| – | – | ﹤0.01% | 536 |
|
|
2023
Q4 | $15.2K | Hold |
3,364
| – | – | ﹤0.01% | 577 |
|
|
2023
Q3 | $13.5K | Sell |
3,364
-87
| -3% | -$346 | ﹤0.01% | 578 |
|
|
2023
Q2 | $13.2K | Buy |
3,451
+75
| +2% | +$278 | ﹤0.01% | 590 |
|
|
2023
Q1 | $12.8K | Sell |
3,376
-1,129
| -25% | -$4.46K | ﹤0.01% | 599 |
|
|
2022
Q4 | $16.9K | Sell |
4,505
-530
| -11% | -$1.83K | ﹤0.01% | 601 |
|
|
2022
Q3 | $17K | Buy |
5,035
+737
| +17% | +$2.68K | ﹤0.01% | 574 |
|
|
2022
Q2 | $15K | Sell |
4,298
-1,402
| -25% | -$5.35K | ﹤0.01% | 661 |
|
|
2022
Q1 | $24K | Sell |
5,700
-195
| -3% | -$881 | ﹤0.01% | 646 |
|
|
2021
Q4 | $26K | Buy |
5,895
+350
| +6% | +$1.59K | ﹤0.01% | 574 |
|
|
2021
Q3 | $27K | Sell |
5,545
-303
| -5% | -$1.51K | ﹤0.01% | 551 |
|
|
2021
Q2 | $30K | Buy |
5,848
+229
| +4% | +$1.23K | ﹤0.01% | 508 |
|
|
2021
Q1 | $30K | Sell |
5,619
-1,218
| -18% | -$7.2K | ﹤0.01% | 498 |
|
|
2020
Q4 | $36K | Buy |
6,837
+163
| +2% | +$806 | ﹤0.01% | 448 |
|
|
2020
Q3 | $31K | Sell |
6,674
-56
| -0.8% | -$272 | ﹤0.01% | 457 |
|
|
2020
Q2 | $30K | Buy |
6,730
+370
| +6% | +$1.54K | ﹤0.01% | 415 |
|
|
2020
Q1 | $27K | Hold |
6,360
| – | – | ﹤0.01% | 402 |
|
|
2019
Q4 | $33K | Hold |
6,360
| – | – | ﹤0.01% | 500 |
|
|
2019
Q3 | $27K | Buy |
6,360
+2,886
| +83% | +$11K | ﹤0.01% | 534 |
|
|
2019
Q2 | $12K | Sell |
3,474
-844
| -20% | -$2.95K | ﹤0.01% | 618 |
|
|
2019
Q1 | $16K | Buy |
4,318
+556
| +15% | +$2.17K | ﹤0.01% | 607 |
|
|
2018
Q4 | $14K | Buy |
3,762
+398
| +12% | +$1.78K | 0.01% | 305 |
|
|
2018
Q3 | $16K | Sell |
3,364
-134
| -4% | -$634 | ﹤0.01% | 516 |
|
|
2018
Q2 | $17K | Buy |
+3,498
| New | +$19.1K | 0.01% | 295 |
|
|
2018
Q1 | – | Sell |
-5,575
| Closed | -$32K | – | 639 |
|
|
2017
Q4 | $32K | Hold |
5,575
| – | – | 0.01% | 370 |
|
|
2017
Q3 | $31K | Buy |
5,575
+4,342
| +352% | +$24.9K | ﹤0.01% | 649 |
|
|
2017
Q2 | $7K | Sell |
1,233
-237
| -16% | -$1.45K | ﹤0.01% | 385 |
|
|
2017
Q1 | $9K | Sell |
1,470
-1,823
| -55% | -$11.7K | ﹤0.01% | 390 |
|
|
2016
Q4 | $19K | Buy |
3,293
+379
| +13% | +$2.02K | ﹤0.01% | 386 |
|
|
2016
Q3 | $12K | Buy |
2,914
+1
| +0% | +$4 | ﹤0.01% | 456 |
|
|
2016
Q2 | $11K | Sell |
2,913
-210
| -7% | -$875 | ﹤0.01% | 430 |
|
|
2016
Q1 | $13K | Sell |
3,123
-577
| -16% | -$2.73K | ﹤0.01% | 474 |
|
|
2015
Q4 | $18K | Buy |
3,700
+471
| +15% | +$2.87K | ﹤0.01% | 385 |
|
|
2015
Q3 | $21K | Buy |
+3,229
| New | +$21.4K | ﹤0.01% | 343 |
|
|
2015
Q2 | – | Sell |
-3,229
| Closed | -$19K | – | 567 |
|
|
2015
Q1 | $19K | Buy |
+3,229
| New | +$18.5K | ﹤0.01% | 387 |
|
Other funds holding NMR
DSC
Zions Bancorporation's NMR Position: Q4 2024 in Review
Zions Bancorporation reduced its Nomura Holdings (NMR) stake by 21% in Q4 2024, selling an estimated $2.1K and leaving 1,434 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #643.
Zions Bancorporation first reported a position in NMR in Q1 2015 and has held it in 38 quarters since. The position peaked at $36K in Q4 2020. 207 funds tracked by Wall St. Rank hold NMR as of Q4 2024.
- Zions Bancorporation held 1,434 shares of Nomura Holdings worth $8.3K as of Q4 2024.
- Zions Bancorporation sold 370 Nomura Holdings shares in Q4 2024, an estimated $2.1K.
- Nomura Holdings made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #643 holding.
- Zions Bancorporation first reported a position in Nomura Holdings in Q1 2015 and has held it in 38 quarters since.
- Zions Bancorporation's Nomura Holdings position peaked at $36K in Q4 2020.
- 207 funds tracked by Wall St. Rank held Nomura Holdings as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.